India's Pharmaceutical Exports

Country Profile

Liberia

Liberia is an emerging destination for Indian pharmaceutical exports — $22.9M in FY 2025–26, with 2.9× growth over the past decade. Medicines accounts for 92% of shipments, with vaccines contributing $766K. The compound annual growth rate since FY2015 stands at 10.2%.

🇱🇷 $22.9M · 2.9× growth since FY2015 · 10.2% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$22.9M
Exports FY2025–26 DGCIS
2.9×
Growth FY2015→2026
10.2%
CAGR FY2015→2026
92%
Medicines Share
5
Product Categories Supplied
Liberia is an emerging destination for Indian pharmaceutical exports — $22.9M in FY 2025–26, with 2.9× growth over the past decade. Medicines accounts for 92% of shipments, with vaccines contributing $766K. The compound annual growth rate since FY2015 stands at 10.2%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $21.1M (92.0%) Vaccines $766K (3.3%) Surgical & Hospital Supplies $624K (2.7%) Traditional & Herbal $264K (1.2%) Medicine Ingredients $175K (0.8%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Liberia in the RBI overseas direct investment dataset (2011–2026).